SThree plc
28 September 2006
28 September 2006
SThree plc
Exercise of Options, Gifts pursuant to the Share Gift Plan and Share Sale
Further to its announcement earlier today, SThree plc ('SThree' or the
'Company') announces that 6,861,578 shares in the Company ('Shares') being sold
by employees were today sold at a price of 317 pence per Share.
As part of the above, the following senior managers sold Shares as follows:
Number of shares % of issued capital
Ian Michael Colletts 3,840 <0.1%
Gary Christopher Goldsmith 1,700,000 1.23%
Timothy Alwyn Lloyd 1,100,000 0.79%
Following the sale the following senior management have beneficial interests in
ordinary shares of 1p each in the Company as follows:
Number of shares % of issued capital No of shares
under options
Ian Michael Colletts 75,000 <0.1% 0
Gary Christopher Goldsmith 300,000 0.21% 3,341,898
Timothy Alwyn Lloyd 1,101,735 0.80& 0
This announcement is intended to satisfy obligations under both the Disclosure
Rules 3.14R(1) and S329 of the Companies Act 1985.
Ian Colletts
Company Secretary
020 7292 3838
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.